Active Ingredient(s): Copper Dotatate Cu-64
FDA Approved: * September 3, 2020
Pharm Company: * RADIOMEDIX
Category: Diagnostic Aid

Copper (64Cu) oxodotreotide or Copper Cu 64 dotatate, sold under the brand name Detectnet, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults.[2] Common side effects include nausea, vomiting and flushing.[3] It was approved for medical use in the United States in September 2020.[2][3] Contents 1 His... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Detectnet 1 mci/Ml Intravenous Injection, Solution
NDC: 69945-064
Curium Us LLC